← Eichor
Study identifier: NCT06928649 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies

Condition: Sepsis · Trauma Related Injuries · Subarachnoid Haemorrhage (SAH)  ·  Sponsor: University Hospital, Antwerp

PhaseNA
Planned participants600
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In order to better determine which therapy is best for patiënts which present with organ falure during the course of their stay in the intesive care unit (ICU) , one has to determine which underlying mechanism is causing this organ falure. We will determine levels of so called "biomarkers" for ferroptosis (a mechan ism of iron-related cell death) in the peripheral blood and biological fluids of criticaly ill patients admitted to the ICU with a catastrrophy (severe infection, trauma ...) . Why ? If it turns out that this ferroptosis plays a role in the ocurrence of organ failure in the critially ill, this will lead to new therapies in the future as drugs become more and more available which can influene this biochemical "pahway". of iron-relatd death.

This description comes directly from the study's public registry record.

Talk to the study team

Tom Stroobants, MD  ·  +32 3 821 / 24 52  ·  tom.stroobants@uza.be

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital AntwerpEdegem, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06928649